Zobrazeno 1 - 10
of 717 199
pro vyhledávání: '"Protein Kinase Inhibitors / administration '
Autor:
Ma S; Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Wang X; Department of Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China., Yan S; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Miao L; Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China., Wan X; Department of Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China., Ding D; Department of Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China., Yu D; Department of Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China., Diao X; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China., Wang X; Department of Clinical Research Center, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China. wxq@cttq.com., Zhang H; Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China. zhanghua_suzhou@163.com.; Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, China. zhanghua_suzhou@163.com.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Nov; Vol. 94 (5), pp. 647-657. Date of Electronic Publication: 2024 Mar 20.
Autor:
Perrier M; Department of Gastroenterology and Digestive Oncology, Université Reims Champagne-Ardenne, BioSpecT, CHU Reims, Reims, France., Zuccaro E; Department of Pharmacy, Université Reims Champagne-Ardenne, BioSpecT, CHU Reims, Reims, France., Carlier C; Oncology Day-Hospital, CHU Reims, Reims, France., Brugel M; Department of Gastroenterology, CH de la Côte Basque, Bayonne, France., Slimano F; Department of Pharmacy, Université Reims Champagne-Ardenne, BioSpecT, CHU Reims, Reims, France., Bouché O; Department of Gastroenterology and Digestive Oncology, Université Reims Champagne-Ardenne, BioSpecT, CHU Reims, Reims, France.
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Dec; Vol. 30 (8), pp. 1432-1436. Date of Electronic Publication: 2024 Aug 01.
Autor:
Bauman JN; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.) jonathan.bauman@pfizer.com., Doran AC; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Gualtieri GM; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Hee B; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Strelevitz T; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Cerny MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Banfield C; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Plotka A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Wang X; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Purohit VS; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Dowty ME; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Sep 16; Vol. 52 (10), pp. 1124-1136. Date of Electronic Publication: 2024 Sep 16.
Autor:
Kumar A; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam 781101, India., Vaiphei KK; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam 781101, India., Gulbake A; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam 781101, India. Electronic address: arvind@niperguwahati.in.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Dec 05; Vol. 666, pp. 124745. Date of Electronic Publication: 2024 Sep 23.
Autor:
Caquelin L; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Badra P; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France.; ReCAP/F-CRIN, INSERM, Paris, France., Poulain L; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Laviolle B; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France., Ursino M; ReCAP/F-CRIN, INSERM, Paris, France.; Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debré, Inserm CIC-EC 1426, Paris, France.; Inserm, Centre de Recherche des Cordeliers, Université Paris Cité, Sorbonne Université, Paris, France.; Inria Paris, Paris, France., Locher C; Univ Rennes, CHU Rennes, Inserm, Centre d'investigation clinique de Rennes (CIC1414), Service de Pharmacologie Clinique, Institut de Recherche en Santé, Environnement et Travail (Irset), UMR S 1085, EHESP, Rennes, France.; ReCAP/F-CRIN, INSERM, Paris, France.
Publikováno v:
Research synthesis methods [Res Synth Methods] 2024 Nov; Vol. 15 (6), pp. 964-977. Date of Electronic Publication: 2024 Aug 05.
Autor:
Mesinkovska N; School of Medicine, University of California, Irvine, California, USA., King B; Yale University School of Medicine, New Haven, Connecticut, USA., Zhang X; The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China., Guttman-Yassky E; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Magnolo N; University Hospital Münster, Münster, Germany., Sinclair R; Sinclair Dermatology, Melbourne, Victoria, Australia., Mizuashi M; Tohoku University Graduate School of Medicine, Sendai, Japan., Shapiro J; New York University School of Medicine, New York, New York, USA., Peeva E; Pfizer Inc, Cambridge, Massachusetts, USA., Banerjee A; Pfizer Inc, Cambridge, Massachusetts, USA., Takiya L; Pfizer Inc, Collegeville, Pennsylvania, USA., Cox LA; Pfizer Inc, Cambridge, Massachusetts, USA., Wajsbrot D; Pfizer Inc, New York, New York, USA., Kerkmann U; Pfizer Pharma GmbH, Berlin, Germany., Law E; Pfizer Inc, New York, New York, USA., Wolk R; Pfizer Inc, Groton, Connecticut, USA., Schaefer G; Pfizer Pharma GmbH, Berlin, Germany.
Publikováno v:
The Journal of dermatology [J Dermatol] 2024 Nov; Vol. 51 (11), pp. 1414-1424. Date of Electronic Publication: 2024 Sep 27.
Autor:
Heath EI; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA. heathe@karmanos.org.; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA. heathe@karmanos.org., Chen W; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Choi JE; Michigan Center for Translational Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USA., Dobson K; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Smith M; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA., Maj T; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Kryczek I; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Zou W; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Chinnaiyan AM; Michigan Center for Translational Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA.; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Qiao Y; Michigan Center for Translational Pathology, University of Michigan School of Medicine, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2024 Dec; Vol. 42 (6), pp. 675-684. Date of Electronic Publication: 2024 Nov 06.
Autor:
Chen Y; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Jia L; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Li Y; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Cui W; Emergency Medicine Department, Xuanwu Hospital, Capital Medical University, Beijing, China., Wang J; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Zhang C; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Bian C; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Wang Z; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Lin D; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China., Luo T; Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Taoluo35@126.com.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Nov; Vol. 31 (12), pp. 7860-7869. Date of Electronic Publication: 2024 Aug 01.
Autor:
Kollipara S; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090, Telangana, India., Chougule M; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090, Telangana, India., Boddu R; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090, Telangana, India., Bhatia A; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090, Telangana, India., Ahmed T; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd, Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090, Telangana, India. tausifahmed@drreddys.com.
Publikováno v:
The AAPS journal [AAPS J] 2024 Jun 11; Vol. 26 (4), pp. 66. Date of Electronic Publication: 2024 Jun 11.
Autor:
Pamuk GE; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chow ECY; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ionan AC; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Chen H; Office of Biostatistics, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Lee SL; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Hsu V; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Grimstein M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Zheng N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Sun J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Gehrke BJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Vallejo J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Ehrlich LA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., de Claro RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland., Theoret MR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4266-4271.